MannKind | Laba Kotor Pada Penjualan



Gross Profit On Sales Perubahan Tanggal
Adma Biologics USD 63.33M 3.67M 2024-12
Dynavax Technologies USD 78.57M 24.17M 2025-06
Eli Lilly USD 13.11B 2.61B 2025-06
Halozyme Therapeutics USD 279.36M 62.9M 2025-06
Insmed USD 78.08M 6.53M 2025-06
MacroGenics USD 13.86M 94.98M 2024-12
MannKind USD 1.89M 59.45M 2025-06
Merck USD 12.99B 224M 2025-06
Novo Nordisk DKK 65.2B 5.19B 2025-03
Pfizer USD 10.88B 248M 2025-06
Sanofi EUR 7.74B 26M 2025-06
Xencor 43.61M 10.88M 2025-06


MannKind Laba Kotor Pada Penjualan - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Aug 2025.